Follow
Völgyi Gergely
Völgyi Gergely
Egis Gyógyszergyár Zrt.
Verified email at egis.hu
Title
Cited by
Cited by
Year
Potentiometric and spectrophotometric pKa determination of water-insoluble compounds: validation study in a new cosolvent system
G Völgyi, R Ruiz, K Box, J Comer, E Bosch, K Takács-Novák
Analytica chimica acta 583 (2), 418-428, 2007
2062007
Study of pH-dependent solubility of organic bases. Revisit of Henderson-Hasselbalch relationship
G Völgyi, E Baka, KJ Box, JEA Comer, K Takács-Novák
Analytica Chimica Acta 673 (1), 40-46, 2010
1382010
Equilibrium versus kinetic measurements of aqueous solubility, and the ability of compounds to supersaturate in solution—a validation study
KJ Box, G Völgyi, E Baka, M Stuart, K Takács-Novák, JEA Comer
Journal of pharmaceutical sciences 95 (6), 1298-1307, 2006
1302006
Equilibrium solubility measurement of ionizable drugs–consensus recommendations for improving data quality
A Avdeef, E Fuguet, A Llinàs, C Ràfols, E Bosch, G Völgyi, T Verbić, ...
Admet and Dmpk 4 (2), 117-178, 2016
1192016
Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid
K Takács-Novák, V Szőke, G Völgyi, P Horváth, R Ambrus, ...
Journal of pharmaceutical and biomedical analysis 83, 279-285, 2013
592013
Chiral separation of asenapine enantiomers by capillary electrophoresis and characterization of cyclodextrin complexes by NMR spectroscopy, mass spectrometry and molecular modeling
ZI Szabó, G Tóth, G Völgyi, B Komjáti, G Hancu, L Szente, T Sohajda, ...
Journal of Pharmaceutical and Biomedical Analysis 117, 398-404, 2016
552016
Predicting the exposure and antibacterial activity of fluoroquinolones based on physicochemical properties
G Völgyi, G Vizserálek, K Takács-Novák, A Avdeef, KY Tam
European journal of pharmaceutical sciences 47 (1), 21-27, 2012
452012
Prediction of bioequivalence and food effect using flux-and solubility-based methods
E Borbás, S Kádár, K Tsinman, O Tsinman, D Csicsák, K Takács-Novák, ...
Molecular Pharmaceutics 16 (10), 4121-4130, 2019
412019
Salt solubility products of diprenorphine hydrochloride, codeine and lidocaine hydrochlorides and phosphates–Novel method of data analysis not dependent on explicit solubility …
G Völgyi, A Marosi, K Takács-Novák, A Avdeef
ADMET and DMPK 1 (4), 48-62, 2013
402013
Physicochemical Properties of a New Multicomponent Cosolvent System for the pKa Determination of Poorly Soluble Pharmaceutical Compounds
KJ Box, G Völgyi, R Ruiz, JE Comer, K Takács‐Novák, E Bosch, C Ràfols, ...
Helvetica Chimica Acta 90 (8), 1538-1553, 2007
352007
Monte Carlo structure simulations for aqueous 1, 4-dioxane solutions
PI Nagy, G Völgyi, K Takács-Novák
The Journal of Physical Chemistry B 112 (7), 2085-2094, 2008
322008
Effect of solubility enhancement on nasal absorption of meloxicam
T Horváth, R Ambrus, G Völgyi, M Budai-Szűcs, Á Márki, P Sipos, ...
European Journal of Pharmaceutical Sciences 95, 96-102, 2016
272016
Physicochemical characterisation and cyclodextrin complexation of erlotinib
G Tóth, Á Jánoska, ZI Szabó, G Völgyi, G Orgován, L Szente, B Noszál
Supramolecular Chemistry 28 (7-8), 656-664, 2016
232016
Physicochemical characterization and cyclodextrin complexation of the anticancer drug lapatinib
G Tóth, Á Jánoska, G Völgyi, ZI Szabó, G Orgován, A Mirzahosseini, ...
Journal of Chemistry 2017, 2017
222017
Effect of formulation additives on drug transport through size-exclusion membranes
E Borbás, P Tőzsér, K Tsinman, O Tsinman, K Takács-Novák, G Völgyi, ...
Molecular pharmaceutics 15 (8), 3308-3317, 2018
202018
Equilibrium solubility measurement of compounds with low dissolution rate by Higuchi's Facilitated Dissolution Method. A validation study
K Takács-Novák, M Urac, P Horváth, G Völgyi, BD Anderson, A Avdeef
European Journal of Pharmaceutical Sciences 106, 133-141, 2017
202017
Tapentadol enantiomers: synthesis, physico-chemical characterization and cyclodextrin interactions
I Fejős, Y He, G Völgyi, A Kazsoki, J Sun, W Chen, T Sohajda, L Szente, ...
Journal of Pharmaceutical and Biomedical Analysis 88, 594-601, 2014
192014
RPTLC determination of log P of structurally diverse neutral compounds
G Völgyi, K Deák, J Vámos, K Valkó, K Takács-Novák
JPC-Journal of Planar Chromatography-Modern TLC 21 (2), 143-149, 2008
182008
Right filter-selection for phase separation in equilibrium solubility measurement
G Völgyi, D Csicsák, K Takács-Novák
European Journal of Pharmaceutical Sciences 123, 98-105, 2018
172018
Tautomeric and conformational equilibria of tyramine and dopamine in aqueous solution
PI Nagy*, G Völgyi, K Takács-Novák §
Molecular Physics 103 (11-12), 1589-1601, 2005
172005
The system can't perform the operation now. Try again later.
Articles 1–20